| Filed pursuant to Rule 433 | ||
Pricing Term Sheet dated as of March 6, 2013 | ||
| Registration File No. 333-180608 | ||
| Supplementing the Preliminary | ||
| Prospectus Supplement | ||
| dated March 1, 2013 |
MASTEC, INC.
4.875% SENIOR NOTES DUE 2023
| Issuer: | MasTec, Inc. | |
| Ratings: | Ba3 (Moody’s) / BB- (S&P)1 | |
| Principal Amount: | $400,000,000, which represents an increase of $50,000,000 from the preliminary prospectus supplement | |
| Security Type: | Senior Notes | |
| Legal Format: | SEC Registered | |
| Trade Date: | March 6, 2013 | |
| Settlement Date: | March 18, 2013 (T+8) | |
| Maturity Date: | March 15, 2023 | |
| Issue Price: | 100% of principal amount | |
| Gross Spread: | 1.50% of principal amount | |
| Net Proceeds to Issuer: | $394,000,000 | |
| Coupon: | 4.875% | |
| Benchmark Treasury: | 2.00% due February 15, 2023 | |
| Spread to Benchmark Treasury: | 293 basis points (2.934%) | |
| Treasury Strike: | 1.941% | |
| All-in Yield: | 4.875% | |
| Interest Payment Dates: | Semi-annually on March 15 and September 15, commencing on September 15, 2013 | |
| Record Dates: | March 1 and September 1 | |
1 Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at
any time.
| Optional Redemption: | The Issuer may redeem the Notes, in whole or in part, at any time on or after March 15, 2018. The redemption price for the Notes (expressed as a percentage of principal amount) will be as follows, plus accrued and unpaid interest, if any, to the redemption date, if redeemed during the 12-month period commencing on March 15 of any year set forth below: |
Year | Redemption Price | |||
2018 | 102.438% | |||
2019 | 101.625% | |||
2020 | 100.813% | |||
2021 and thereafter | 100.000% | |||
In addition, at any time prior to March 15, 2016, the Issuer may redeem up to 35% of the principal amount of the Notes with an amount equal to the amount of the Net Cash Proceeds of one or more sales of Capital Stock (other than Disqualified Stock) of the Issuer at a redemption price (expressed as a percentage of principal amount) of 104.875%, plus accrued and unpaid interest to the redemption date; provided that at least 65% of the aggregate principal amount of the Notes originally issued on the Closing Date remains outstanding after each such redemption (excluding Notes held by the Issuer and its Subsidiaries) and notice of any such redemption is mailed within 90 days of each such sale of Capital Stock.
In addition, at any time prior to March 15, 2018, the Issuer may redeem all or a part of the Notes at a redemption price equal to 100% of the principal amount of Notes redeemed plus the Applicable Premium as of, and accrued and unpaid interest, if any, to, the redemption date, subject to the rights of holders of notes on the relevant record date to receive interest due on the relevant interest payment date. | ||
| Denominations: | $2,000 and multiples of $1,000 in excess thereof. | |
| CUSIP: | 576323AN9 | |
| ISIN: | US576323AN93 | |
| Underwriters: | Barclays Capital (37.5%) (joint bookrunner) | |
| Morgan Stanley (21.25%) (joint bookrunner) | ||
| SunTrust Robinson Humphrey (21.25%) (joint bookrunner) | ||
| FBR (7.5%) | ||
| KeyBanc Capital Markets (7.5%) | ||
| Stifel (5.0%) | ||
The information in this communication supersedes the information in the preliminary prospectus supplement to the extent it is inconsistent with such information. Other information presented in the preliminary prospectus supplement is deemed to have changed to the extent affected by the changes described herein.
The issuer has filed a registration statement (including a prospectus) with the U.S. Securities and Exchange Commission (SEC) for this offering. Before you invest, you should read the prospectus for this offering in that registration statement, and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by searching the SEC online database (EDGAR®) atwww.sec.gov. Alternatively, you may obtain a copy of the prospectus from Barclays Capital Inc. by calling 1-888-227-2275, extension 2663.
Any disclaimers or other notices that may appear below are not applicable to this communication and should be disregarded. Such disclaimers or other notices were automatically generated as a result of this communication being sent via Bloomberg email or another communication system.